Bioventus Inc. BVS: Stock price, financial analysis and comparison with its peers
Stock - BVS
Bioventus Inc.
Prices and values in USD currency
Price - $5.2
Price is the close price as of yesterday market close (i.e. 2024-03-28). Prices are not updated in real time.
Sector
Healthcare
Industry
Health Care Providers
Employees
700
ISIN
US09075A1088
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include o... See more...
| BVS | CYH | HCA | EAR | |
|---|---|---|---|---|
| Company Name | Bioventus Inc. | Community Health Systems, Inc. | HCA Holdings | Eargo, Inc. |
| Reason for selection | Selected stock | Stock with min Market Cap difference in Industry | Highest market cap. in industry | Highest market cap. in sector |
| Market Cap | $412 M | $470 M | $119,173 M | $1,462,582 M |
| Industry | Health Care Providers | Health Care Providers | Health Care Providers | Medical Devices |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare |
| Total Equity | $340 M | ************************* | ************************* | ************************* |
| Shares Outstanding | 79 M | ************************* | ************************* | ************************* |
| Close | $5.2 | ************************* | ************************* | ************************* |
| Earning Yield | NaN% | ************************* | ************************* | ************************* |
| ROIC | -32.26% | ************************* | ************************* | ************************* |
| Current Ratio | 0.9 | ************************* | ************************* | ************************* |
| TBI Financial Score | 5 | ************************* | ************************* | ************************* |
| Preferred Stocks | NaN | ************************* | ************************* | ************************* |
| Total Capitalization | NaN | ************************* | ************************* | ************************* |
| Book Value per Share | 4 | ************************* | ************************* | ************************* |
| Earning Yield EBITavg3 | NaN% | ************************* | ************************* | ************************* |
| P E (3 years avg) | -10 | ************************* | ************************* | ************************* |
| Net Profit Margin | -30.99% | ************************* | ************************* | ************************* |
| Dividends Yield | nan% | ************************* | ************************* | ************************* |
| Working Capital/Debt | NaN% | ************************* | ************************* | ************************* |
| Net Income | -158704000.0 | ************************* | ************************* | ************************* |
| Net Income 5yGrowth | NaN% | ************************* | ************************* | ************************* |
| Num of Years w Dividends 10y | 2 | ************************* | ************************* | ************************* |
Investment Analysis Report: BVS and his peers
Overview:
Below you'll find an AI powered output based on the selected companies for comparison. If you change the companies, the output will be re-calculated.
For the analysis we decided to use Graham (father of value investing) as inspiration, the comparison is structured and oriented as the writer did to compare companies back in his times in the chapter 13 of the famous book The Intelligent Investor.
1. Profitability
2. Stability
| Ticker | Stability Max Drop | # Years Statements | # Years Neg Change | Stability Mean Change |
|---|---|---|---|---|
| CYH | -3.891304347826087 | 5 | 2 | -234.61% |
| HCA | -0.07106149211412371 | 3 | 1 | 1.39% |
| EAR | 4 | 0 | NaN% |
| Ticker | Rank Stability |
|---|---|
| CYH | 1.0 |
3. Growth
4. Financial Position
5. Dividends
| Ticker | # years with dividends 10y |
|---|---|
| HCA | 3 |
| CYH | 0 |
| EAR | 0 |
| Ticker | Dividends yield |
|---|---|
| HCA | 0.58% |